Sparks: How I use AI to turn failed drugs into new medicines

The survey remains incomplete until we record the negative results as rigorously as the successes, for these abandoned trials are not failures but coordinates that define the boundary of our pharmaceutical knowledge.

What we once dismissed as therapeutic dross achieves consilience when an external logic predicts utility in a domain for which the substance was never designed, proving the hypothesis through unintended success.

It is a triumph of economy to extract profit from the very poisons that failed to cure us, ensuring that no apothecary’s error is ever wasted so long as a machine can find a use for it.

Does the machine truly understand the nature of health, or has it merely learned to rearrange the alphabet of our ignorance until we mistake a hidden pattern for a cure?

The dog finds its medicine in the grass by instinct, while the civilized man builds a giant metal brain to sift through his own expensive trash for a remedy he already lost.

We won the battle against disease only to find ourselves governed by the ghosts of our former failures, requiring a new constitution of thought to liberate the healing power trapped in our own archives.

My inventory of this strange digital landscape reveals a valley of forgotten vials where the local inhabitants have learned to trade in the currency of their own documented mistakes.

Mapping the path to safety requires knowing every dead end as well as the north star, so I use the maps of those who got lost to lead the next group through.

Monsieur Pangloss would be delighted to learn that our most disastrous medical catastrophes were simply the necessary preparation for a computer to discover the best of all possible cures among the wreckage.